AI assistant
Sending…
Axogen, Inc. — Director's Dealing 2022
Nov 10, 2022
32414_dirs_2022-11-10_882e4f93-7c57-47c8-9d2b-3277aaede19e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Axogen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2022-11-08
Reporting Person: Freitag Gregory Gene (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-11-08 | Common Stock | S | 13000 | $12.50 | Disposed | 352583 | Direct |
Footnotes
F1: The sale reported on the this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.
More from Axogen, Inc.
Major Shareholding Notification
2026
May 7
Major Shareholding Notification
2026
Apr 29
Annual Report
2026
Apr 29
Proxy Solicitation & Information Statement
2026
Apr 29
Interim / Quarterly Report
2026
Apr 28
Earnings Release
2026
Apr 28
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3